Some specific driver genes in cancer development such as EGFR, mutations of this gene are found both in cancer lesions and adjacent normal samples, despite of more severe extent of mutations in malignancy, suggesting driver gene mutations need to be further validated particularly for clinical application. The gene discussed is EGFR; the disease is cancer.